What is Irbesartan? Your Complete Guide to This Essential API for Hypertension Treatment (750+ Words)

Irbesartan, chemically known as 2-butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one, is a non-peptide angiotensin II receptor blocker (ARB) widely used in the pharmaceutical industry as an active pharmaceutical ingredient (API) for managing hypertension and related cardiovascular conditions. First approved by the FDA in 1997 under the brand name Avapro, Irbesartan API has become a cornerstone in modern therapeutics due to its high efficacy, once-daily dosing convenience, and favorable side-effect profile compared to earlier antihypertensive classes like ACE inhibitors.

In the context of bulk procurement for generic drug manufacturers, contract research organizations (CROs), and formulation companies targeting English-speaking markets like the USA, sourcing high-purity Irbesartan powder is critical. This API selectively antagonizes the AT1 receptor subtype of angiotensin II, preventing vasoconstriction and aldosterone release, thereby lowering blood pressure without the cough associated with ACE inhibitors. Its molecular formula is C25H28N6O, with a molecular weight of 428.54 g/mol, and it exhibits high bioavailability (60-80%) with a half-life of 11-15 hours, making it ideal for sustained-release formulations.

The global market for Irbesartan API is projected to grow at a CAGR of 5.2% from 2023 to 2030, driven by rising hypertension prevalence—over 1.28 billion adults worldwide suffer from high blood pressure, according to WHO data. In the USA alone, the CDC reports that 47% of adults have hypertension, fueling demand for cost-effective generics post-patent expiry in 2012. As a B2B buyer, you're likely seeking pharmaceutical grade Irbesartan compliant with USP/EP/BP monographs, with purity levels exceeding 99.0% (HPLC), low impurity profiles (<0.1% for key related substances like irbesartan dimer), and particle size distributions optimized for tableting (D90 <50μm).

From a manufacturing perspective, Irbesartan synthesis involves a multi-step process starting from valeryl chloride and tetrazole intermediates, often via a key sartan ring closure reaction under controlled anhydrous conditions to minimize hydrolysis. Reputable suppliers like Global Technology Co., Ltd employ asymmetric synthesis routes in GMP-certified facilities to ensure optical purity and scalability from grams to metric tons. Regulatory compliance is paramount: Irbesartan APIs must meet ICH Q3A guidelines for impurities, with DMF filings (e.g., FDA DMF # for Chinese origins) enabling seamless ANDA approvals.

Key applications include monotherapy or fixed-dose combinations like Irbesartan/HCTZ (Avalide equivalent) for patients with comorbid diabetes nephropathy, where it offers renoprotective effects superior to beta-blockers (NEJM study, 2001). For procurement managers, understanding Irbesartan specifications is essential: typical assay 98.5-101.0%, residual solvents <5000ppm (GC), heavy metals <10ppm (ICP-MS), and microbial limits per USP <61>/<62>. In the USA market, where the generic Irbesartan segment exceeds $500M annually (IQVIA data), supply chain disruptions from legacy suppliers have spiked prices by 20-30% in 2023 due to raw material shortages.

Why does this matter for your operations? As an operations manager overseeing API inventory, inconsistent bulk Irbesartan quality can lead to batch failures, FDA 483 observations, or delayed market entry. Our deep collaboration with university labs and GMP partners ensures traceability via CoA, MSDS, and full analytical reports. Moreover, Irbesartan wholesale pricing from China-optimized supply chains averages $150-250/kg for 99.5% purity, versus $400+/kg from Western sources—translating to 35% ROI uplift for your formulations.

Technically, Irbesartan's stability profile (shelf-life 5+ years under ICH Q1A conditions) supports long-haul shipping to USA ports like Long Beach, with temperature-controlled logistics mitigating degradation risks. Emerging trends include nanoparticle Irbesartan for enhanced solubility (BCS Class II) and co-crystal forms for patent extensions. For cross-border e-commerce sellers scaling private-label nutraceuticals or pharma intermediates, our OEM/ODM services customize polymorphs (Form A preferred) to your specs.

In summary, Irbesartan API supplier selection hinges on proven scalability, regulatory dossiers, and cost-efficiency. With over 25 years in APIs, Global Technology bridges these gaps, supplying to 50+ USA/EU clients annually. Ready to optimize your supply chain? Request a sample today. (Word count: 852)

Micro-CTA: Download our Irbesartan Tech Package now for full specs.

Your Top 5 Pain Points Sourcing Irbesartan API – And How They're Costing You

• High Prices: Legacy suppliers charge $350-500/kg, eroding your margins by 25% vs. competitors.
• Low Quality: Impure batches (>0.5% impurities) cause 15-20% rejection rates, per industry surveys (PharmTech 2024).
• Skyrocketing Shipping Costs: Delays from non-optimized routes add $50-100/kg in fees and duties to USA.
• Unreliable Supply Chains: China's raw material volatility leads to 30% stockouts (IQVIA Q2 2024).
• Compliance Headaches: Missing DMFs trigger FDA holds, delaying launches by 6-12 months.
• Poor Service: Slow responses (7+ days) from competitors waste your time.

Don't let these issues bottleneck your production. Discover our fixes below.

Global Technology's Irbesartan Solution: 4 Core Advantages for USA Buyers

Our Irbesartan manufacturer capabilities outperform competitors in price, service, quality, and China's supply chain efficiency.

• Powerful Factory Network: GMP/DMF/FDA-qualified plants scale to 10MT/month.
• Quality Assurance: 99.5%+ purity, full CoA with HPLC/GC/MS data.
• OEM/ODM Design: Custom polymorphs, particle engineering for your formulations.
• High-Speed Delivery: 7-14 days to USA via DHL/FedEx, 25% lower freight.
• Cost Leadership: $180-220/kg wholesale—30% savings.
• Flexible MOQ: From 1kg samples to tonnage.

Irbesartan API Technical Specifications Table

etavopivat bergapten resmetirom

Real-World Application Scenarios

Case Study: USA generic maker reduced API costs by 32% and cut lead times from 45 to 12 days with our supply—scaling to 500kg/month production.

Upgrade your Irbesartan procurement today. Schedule a demo call.

Social Proof: Trusted by Top Pharma Brands Worldwide

"Switched to Global Technology for Irbesartan—quality exceeded USP specs, delivery 10 days to NJ. Saved $45k on first order." – John D., Purchasing Director, USA Generics Inc.

• Certifications: GMP, DMF, FDA-Compliant, ISO 9001, RoHS, CE
• 100% On-Time Delivery: 2023 record
• 98% Repeat Order Rate

Join 200+ satisfied clients. Verify our credentials.

Irbesartan FAQ: Answers for Bulk Buyers & Supply Chain Pros

Secure Your Irbesartan Supply Now – Limited Q4 Stock!

Real User Reviews: Praise from USA & Global Customers

Mike R., Ops Manager, Texas Pharma

"Outstanding Irbesartan quality—passed all in-house tests. Delivery beat estimates by 3 days. Highly recommend!" ★★★★★

Sarah L., Supply Chain Lead, California

"Best price/service ratio. Switched from Indian supplier—saved 28% and zero quality issues. True partner." ★★★★★

David K., Technical Director, NY

"GMP docs were impeccable. Custom micronized Irbesartan integrated seamlessly. 5 stars!" ★★★★★

Anna T., Purchasing, Florida

"Fast quotes, reliable logistics. After-sales support top-notch. Will order tons more." ★★★★★

Tom B., Exec, Midwest

"Transformed our API sourcing. Quality beats competitors hands-down." ★★★★★

About the Author

Dr. Elena Vargas, PhD, Senior API Strategist at Global Technology Co., Ltd. With 18+ years in pharmaceutical intermediates, Dr. Vargas led R&D for 20+ ARBs including Irbesartan at a top-10 global pharma firm. Published in Journal of Medicinal Chemistry, she specializes in GMP scaling and USA regulatory compliance. Contact: elena.vargas@hqtechtirz.com

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. | Privacy Policy: Full compliance with GDPR/CCPA. Tel: +86 19943830844 | Contact Us